Cromsource expands in Italy; SRI debuts cancer R&D tech;

> European CRO Cromsource expanded its Verona, Italy, headquarters, adding on a 16,000-square-foot facility to accommodate its growth. Item

> CRO SRI International has rolled out its PDCellX tumor models for R&D, touting the technology as better for efficacy studies than standard cell lines. News

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.